ArticleInternational journal of ophthalmology2018

One-year real-world outcomes of ranibizumab 0.5 mg treatment in Taiwanese patients with polypoidal choroidal vasculopathy: a subgroup analysis of the REAL study.

San-Ni Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.